Skip to content

Back

FDADrugsRecalled

Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Read the official notice on accessdata.fda.gov
What's wrong
Failed Dissolution Specifications: below specification
Products
  • Ranolazine Extended-Release Tablets
Company
Ajanta Pharma USA Inc
Where it was sold

Nationwide in the US.

Status
Ongoing

Recall Relay is not affiliated with or endorsed by FDA or any agency. Details here are copied from the FDA notice and may lag behind it; the official notice is always the final word.